Related Experiment Videos
[Detection of circulating immune complexes by the C1q complement fraction deviation test. 1st application in the
Insights
The C1q deviation test detects immune complexes in kidney disease. Positive results were common in acute and membranous glomerulonephritis, suggesting immune complex involvement.
Area of Science:
- Nephrology
- Immunology
- Clinical Chemistry
Background:
- Circulating immune complexes (CICs) are implicated in various kidney diseases.
- The C1q binding assay is a method to detect CICs.
- Understanding CICs' role in glomerulonephritis is crucial for diagnosis and treatment.
Purpose of the Study:
- To evaluate the utility of the C1q deviation test in diagnosing different types of glomerulonephritis.
- To investigate the presence of C1q binding substances in sera of patients with glomerular nephropathies.
Main Methods:
- The C1q deviation test was performed on serum samples from patients with various glomerular nephropathies, hypertension, and healthy controls.
- Radioactive C1q was used to measure its fixation on target cells, assessing interference by immune complexes.
Main Results:
- Positive C1q deviation test results were frequently observed in patients with acute glomerulonephritis and membranous glomerulonephritis.
- Rarer positive results were noted in minimal change disease and membranoproliferative glomerulonephritis.
- The findings suggest that C1q binding substances in pathological sera may include CICs and other factors.
Conclusions:
- The C1q deviation test shows potential in identifying immune complex-related kidney diseases.
- Further research is needed to isolate and identify the specific C1q binding substances in pathological sera.
- Continued investigation can lead to improved diagnostic markers for glomerulonephritis.
Abstract:
The C1q deviation test measures the interference of circulating immune complexes in the fixation of radioactive C1q on target cells. The test was carried out in a large sample of cases of glomerular nephropathies, on the serum of patients with hypertension and on control sera. Positive results were frequently obtained with the sera of patients suffering from acute glomerulonephritis and membranous glomerulonephritis. Positive results were rarer in cases of minimal change discase and of membranoproliferative glomerulonephritis. These results suggest that the deviation of C1q in the serum of patients with various types of glomerulone phropathy may be due to circulating complexes but also to other substances. They indicate that efforts should be continued to isolate and biochemically identify the C1q binding substances in pathological sera.